Amgen (NASDAQ:AMGN) Enters Late-Stage Testing on Weight Loss Drug
We know that weight loss drugs have been big winners for the companies that produce them. And now, biotech stock Amgen (AMGN) ...
Amgen (NasdaqGS:AMGN) Declares US$2 Dividend Per Share For Q2 2025
Amgen (NasdaqGS:AMGN)'s recent affirmation of a $2.38 per share dividend for Q2 2025 could reflect investor confidence and ...
Amgen Inc. (AMGN) 45th Annual TD Cowen Health Care Conference (Transcript)
Amgen Inc. (NASDAQ:AMGN) 45th Annual TD Cowen Health Care Conference Transcript March 5, 2025 9:10 AM ETCompany ParticipantsJay Bradner - Executive ...
News95h
Oklahoma Allergy and Asthma Clinic pushing back against insurance changes
The Oklahoma Allergy and Asthma clinic is pushing back against proposed changes in coverage for asthma medications covered by Blue Cross Blue Shield.
Amgen price target raised to $294 from $275 at BofA
BofA raised the firm’s price target on Amgen (AMGN) to $294 from $275 and keeps an Underperform rating on the shares. For the last several ...